Literature DB >> 22074932

Isolation of Coxsackievirus A24 variant from patients with hemorrhagic conjunctivitis in Cuba, 2008-2009.

Magilé C Fonseca1, Luis Sarmiento, Sonia Resik, Niurka Pereda, Hermis Rodríguez, Vivian Kourí, Pedro Ariel Martínez, Alexander Piñón, Daniel Limonta, Pedro Más, Lai Heng Hung.   

Abstract

BACKGROUND: An outbreak of acute hemorrhagic conjunctivitis occurred in Cuba in 2008 and 2009.
OBJECTIVE: To determinate the etiological agent associated with the Cuban outbreaks of acute hemorrhagic conjunctivitis during 2008 and 2009. STUDY
DESIGN: Conjunctival swabs and/or faecal samples from 382 patients with clinical diagnosis suggestive of acute hemorrhagic conjunctivitis were subject to viral culture in HEp-2 human laryngeal epidermoid carcinoma cells. Positive samples were identified by a specific Coxsackievirus A24 variant PCR and the 3C protease region of 16 isolates was sequenced for phylogenetic analysis.
RESULTS: Enterovirus cytopathic effect was observed in 138 cases (36%). A higher percent of CA24v was recovered from faecal samples, 19 out of 45 cases (42.2%), than from conjunctival swabs, 127 out of 355 samples (35.8%). All isolates were identified as Coxsackievirus A24 variant. Phylogenetic analysis revealed that 2008 and 2009 Cuban outbreaks were caused by the same virus strains and that isolates were closely related to those from Taiwan (2006-2007), China (2007-2008) and Singapore (2005) with a bootstrap value of 71%.
CONCLUSIONS: Outbreaks of acute hemorrhagic conjunctivitis occurred in Cuba in 2008 and 2009 were caused by Coxsackievirus A24 variant. The faecal-oral route is another mode of transmission of CA24v in the acute hemorrhagic conjunctivitis outbreaks. Phylogenetic analysis of Cuban CA24v strains involved in an acute hemorrhagic conjunctivitis outbreak in 2008 and 2009 confirms a new introduction of the CA24 variant into the Americas from South-east Asia.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22074932     DOI: 10.1016/j.jcv.2011.10.006

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  6 in total

Review 1.  The epidemiology of non-polio enteroviruses: recent advances and outstanding questions.

Authors:  Margarita Pons-Salort; Edward P K Parker; Nicholas C Grassly
Journal:  Curr Opin Infect Dis       Date:  2015-10       Impact factor: 4.915

2.  Circulation of multiple serotypes of highly divergent enterovirus C in the Xinjiang Uighur Autonomous Region of China.

Authors:  Yong Zhang; Qiang Sun; Hui Cui; Dongmei Yan; Qin Fan; Yang Song; Shuangli Zhu; Xiaolei Li; Guohong Huang; Tianjiao Ji; Lan Hu; Dongyan Wang; Qian Yang; Wenbo Xu
Journal:  Sci Rep       Date:  2016-09-19       Impact factor: 4.379

3.  Genetic characteristics of the coxsackievirus A24 variant causing outbreaks of acute hemorrhagic conjunctivitis in Jiangsu, China, 2010.

Authors:  Bin Wu; Xian Qi; Ke Xu; Hong Ji; Yefei Zhu; Fenyang Tang; Minghao Zhou
Journal:  PLoS One       Date:  2014-01-24       Impact factor: 3.240

4.  Molecular evolution of coxsackievirus A24v in Cuba over 23-years, 1986-2009.

Authors:  Magilé C Fonseca; Mario Pupo-Meriño; Luis A García-González; Sonia Resik; Lai Heng Hung; Mayra Muné; Hermis Rodríguez; Luis Morier; Heléne Norder; Luis Sarmiento
Journal:  Sci Rep       Date:  2020-08-13       Impact factor: 4.379

5.  Molecular Characterization of Coxsackievirus A24v from Feces and Conjunctiva Reveals Epidemiological Links.

Authors:  Magilé C Fonseca; Mario Pupo-Meriño; Luis A García-González; Mayra Muné; Sonia Resik; Heléne Norder; Luis Sarmiento
Journal:  Microorganisms       Date:  2021-03-05

6.  Molecular analysis of Coxsackievirus A24 variant isolates from three outbreaks of acute hemorrhagic conjunctivitis in 1988, 1994 and 2007 in Beijing, China.

Authors:  Junhan Li; Fang Huang; Yong Zhang; Tianjiao Ji; Shuangli Zhu; Dongyan Wang; Zhenzhi Han; Jinbo Xiao; Fenfen Si; Wenbo Xu; Dongmei Yan
Journal:  Virol Sin       Date:  2022-01-22       Impact factor: 6.947

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.